MAP3K7 and neuromyelitis optica: These factors, such as Bcl-2, NFκB, MAP3K7, TNF-α, and IL-1β, somewhat inhibit apoptosis of CD4+ T cells, which might then interact with B cells and afford an opportunity to clinically relapse in NMO patients.